BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28112371)

  • 61. The intermediate filament vimentin mediates microRNA miR-378 function in cellular self-renewal by regulating the expression of the Sox2 transcription factor.
    Deng Z; Du WW; Fang L; Shan SW; Qian J; Lin J; Qian W; Ma J; Rutnam ZJ; Yang BB
    J Biol Chem; 2013 Jan; 288(1):319-31. PubMed ID: 23135265
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Calpain-6 controls the fate of sarcoma stem cells by promoting autophagy and preventing senescence.
    Andrique C; Morardet L; Linares LK; Cissé MY; Merle C; Chibon F; Provot S; Haÿ E; Ea HK; Cohen-Solal M; Modrowski D
    JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185659
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells.
    Wu Y; Liu S; Xin H; Jiang J; Younglai E; Sun S; Wang H
    Cancer; 2011 Sep; 117(17):3989-98. PubMed ID: 21365617
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Prognostic Value of Cancer Stem Cell Markers in Cervical Cancer: A Systematic Review and Meta-Analysis.
    Fahmi MN; Hertapanndika IN; Kusuma F
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):4057-4065. PubMed ID: 34967589
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The pluripotency network in colorectal cancer pathogenesis and prognosis: an update.
    Voutsadakis IA
    Biomark Med; 2018 Jun; 12(6):653-665. PubMed ID: 29944017
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression.
    Peter ME
    Cell Cycle; 2009 Mar; 8(6):843-52. PubMed ID: 19221491
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pluripotency transcription factors in lung cancer-a review.
    Sławek S; Szmyt K; Fularz M; Dziudzia J; Boruczkowski M; Sikora J; Kaczmarek M
    Tumour Biol; 2016 Apr; 37(4):4241-9. PubMed ID: 26581906
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Potential role of cancer stem cells as biomarkers and therapeutic targets in cervical cancer.
    Sudhalkar N; Rathod NP; Mathews A; Chopra S; Sriram H; Shrivastava SK; Goda JS
    Cancer Rep (Hoboken); 2019 Apr; 2(2):e1144. PubMed ID: 32721115
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Isolation and characterization of mesenchymal stem cells and its antitumor application on ovarian cancer cell line.
    Mohammadian F; Negahdari B
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1744-1753. PubMed ID: 29199459
    [TBL] [Abstract][Full Text] [Related]  

  • 70. TAT-mediated si-hWAPL inhibits the invasion and metastasis of cervical cancer stem cells.
    Gong P; Hu C; Zhou X; Wang R; Duan Z
    Exp Ther Med; 2017 Dec; 14(6):5452-5458. PubMed ID: 29285075
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Downregulation of NUDT21 contributes to cervical cancer progression through alternative polyadenylation.
    Xing Y; Chen L; Gu H; Yang C; Zhao J; Chen Z; Xiong M; Kazobinka G; Liu Y; Hou T
    Oncogene; 2021 Mar; 40(11):2051-2064. PubMed ID: 33619322
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reciprocal interplays between MicroRNAs and pluripotency transcription factors in dictating stemness features in human cancers.
    Vishnubalaji R; Shaath H; Al-Alwan M; Abdelalim EM; Alajez NM
    Semin Cancer Biol; 2022 Dec; 87():1-16. PubMed ID: 36354097
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    Han GH; Kim J; Yun H; Cho H; Chung JY; Kim JH; Hewitt SM
    Cancer Genomics Proteomics; 2021; 18(6):699-713. PubMed ID: 34697063
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tumor-initiating and -propagating cells: cells that we would like to identify and control.
    Tysnes BB
    Neoplasia; 2010 Jul; 12(7):506-15. PubMed ID: 20651980
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The role of developmental HOX genes in cervical cancer].
    López-Romero R; Marrero-Rodríguez D; Romero-Morelos P; Villegas V; Valdivia A; Arreola H; Huerta-Padilla V; Salcedo M
    Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S188-93. PubMed ID: 26462515
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
    Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
    J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review.
    Di Fiore R; Suleiman S; Drago-Ferrante R; Subbannayya Y; Pentimalli F; Giordano A; Calleja-Agius J
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563557
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers.
    Sharma PC; Gupta A
    Transl Cancer Res; 2020 Sep; 9(9):5798-5818. PubMed ID: 35117940
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Editorial: Protein Functional Changes and Signaling Transduction in Cancer Stem Cells.
    Tanabe S
    Front Oncol; 2021; 11():761678. PubMed ID: 34604099
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.